Aclaris Therapeutics Inc (ACRS) Directors and Executive Officers - CSIMarket
CSIMarket
 
Aclaris Therapeutics Inc   (NASDAQ: ACRS)

Aclaris Therapeutics Inc

Officers & Directors


Vincent Milano
Director

William Humphries
Director

Neal Walker
Interim President and Chief Executive Officer, and Chairman of the Board of Directors

Andrew Powell
Director

Maxine Gowen
Director

Andrew Schiff
Director

Bryan Reasons
Director

Kevin Balthaser
Chief Financial Officer

Anand Mehra, M.D.
Director

Christopher Molineaux
Lead Independent Director


Philadelphia, Pennsylvania ,

Aclaris Therapeutics Inc currently has 73 employees.

  News about Aclaris Therapeutics Inc Key Personnel

Aclaris Therapeutics: Charting a Path to Financial Reinvention and Leadership Reinforcement



Aclaris Therapeutics, a prominent player in the healthcare sector, has recently announced significant leadership changes and a strategic business review. The decision comes after a period of financial underperformance, with the company s year-to-date stock performance showing a decline of 12%. Additionally, Aclaris Therapeutics reported a net loss of $115 million for the twelve months leading up to the third quarter of 2023, resulting in a negative return on assets (ROA) of -48.43%. This article delves into the implications of these developments and the potential impact on the company s overall market standing within the healthcare sector.
Transition in Leadership:
One of the significant ch...






ACRS Management Effectiveness ACRS Revenue per Employee ACRS Income per Employee


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.